In Silico Screening of Pyridine Derivatives as Potential DHFR Inhibitors for Anticancer Activity

被引：0
|
作者：
Nerkar, A. G. [1 ]
Ghone, S. A. [1 ]
Sareen, A. [1 ]
Mehta, A. [1 ]
Bhagat, S. A. [1 ]
Mohanraj, K. P. [1 ]
Thaker, A. K. [1 ]
机构：
[1] SVKMs NMIMS Univ, Sch Pharm & Technol Management, Dept Pharmaceut & Med Chem, Bombay 400056, Maharashtra, India
来源：
ASIAN JOURNAL OF CHEMISTRY | 2009年 / 21卷 / 09期
关键词：
In silico screening; Isoniazid; Schiff's bases; DHFR; ADME; Docking; DIHYDROFOLATE-REDUCTASE; BIOLOGICAL-ACTIVITY; DOCKING; DESIGN;
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
In this paper, in silico screening prioritization of some pyridinyl Schiff bases (Schiff bases of isoniazid (INH)) as inhibitors of mammalian dihydrofolate reductase enzyme (DHFR) for anticancer activity, before actual synthesis of the molecules and anticancer evaluation are reported.
引用
收藏
页码：6975 / 6980
页数：6
相关论文
共 50 条
  • [21] Anticancer Activity of Chalcones and Its Derivatives: Review and In Silico Studies
    Leite, Fernando Ferreira
    de Sousa, Natalia Ferreira
    Melo de Oliveira, Bruno Hanrry
    Duarte, Gabrielly Diniz
    Leite Ferreira, Maria Denise
    Scotti, Marcus Tullius
    Barbosa Filho, Jose Maria
    Rodrigues, Luis Cezar
    de Moura, Ricardo Olimpio
    Bezerra Mendonca-Junior, Francisco Jaime
    Scotti, Luciana
    MOLECULES, 2023, 28 (10):
  • [22] Synthesis of Metronidazole Derivatives Containing Pyridine Ring and Anticancer Activity
    Yong, Jianping
    Lu, Canzhong
    Wu, Xiaoyuan
    LETTERS IN ORGANIC CHEMISTRY, 2016, 13 (04) : 283 - 288
  • [23] In silico screening, synthesis, characterization and biological evaluation of novel anticancer agents as potential COX-2 inhibitors
    Sahu, Ankita
    Pradhan, Dibyabhaba
    Veer, Babita
    Kumar, Sumit
    Singh, Ram
    Raza, Khalid
    Rizvi, Moshahid A. A.
    Jain, Arun Kumar
    Verma, Saurabh
    DARU-JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 31 (02) : 119 - 133
  • [24] In silico screening, synthesis, characterization and biological evaluation of novel anticancer agents as potential COX-2 inhibitors
    Ankita Sahu
    Dibyabhaba Pradhan
    Babita Veer
    Sumit Kumar
    Ram Singh
    Khalid Raza
    Moshahid A. Rizvi
    Arun Kumar Jain
    Saurabh Verma
    DARU Journal of Pharmaceutical Sciences, 2023, 31 : 119 - 133
  • [25] Erratum to: Synthesis and anticancer activity of some new pyridine derivatives
    Fatma A. Bassyouni
    Hanaa A. Tawfik
    Abdel Mohsen Soliman
    Mohamed Abdel Rehim
    Research on Chemical Intermediates, 2017, 43 : 4311 - 4311
  • [26] New thiazole-based derivatives as EGFR/HER2 and DHFR inhibitors: Synthesis, molecular modeling simulations and anticancer activity
    Sabry, Mohamed A.
    Ghaly, Mariam A.
    Maarouf, Azza R.
    El-Subbagh, Hussein I.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 241
  • [27] Design, Microwave-Assisted Synthesis, Antimicrobial and Anticancer Evaluation, and In Silico Studies of Some 2-Naphthamide Derivatives as DHFR and VEGFR-2 Inhibitors
    Pham, Em Canh
    Truong, Tuyen Ngoc
    ACS OMEGA, 2022, 7 (37): : 33614 - 33628
  • [28] Recent Design and Structure-Activity Relationship Studies on the Modifications of DHFR Inhibitors as Anticancer Agents
    Wrobel, Agnieszka
    Drozdowska, Danuta
    CURRENT MEDICINAL CHEMISTRY, 2021, 28 (05) : 910 - 939
  • [29] New Thiazolyl-Pyrazoline Derivatives as Potential Dual EGFR/HER2 Inhibitors: Design, Synthesis, Anticancer Activity Evaluation and In Silico Study
    Fakhry, Mariam M.
    Mattar, Amr A.
    Alsulaimany, Marwa
    Al-Olayan, Ebtesam M.
    Al-Rashood, Sara T.
    Abdel-Aziz, Hatem A.
    MOLECULES, 2023, 28 (21):
  • [30] Heterocyclic Compounds and their Derivatives with Potential Anticancer Activity
    Kaur, Avneet
    Shakya, Ashok K.
    Singh, Rohit
    Badhwar, Reena
    Sawhney, Shalini Kapoor
    INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2024, 58 (01) : S26 - S39
12345